We are live on
!
Find out more
Denali Therapeutics
DNLI
DNLI
114 hedge funds and large institutions have $1.6B invested in Denali Therapeutics in 2019 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,300% more call options, than puts
Call options by funds: $48K | Put options by funds: $2K
343% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 7
42% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 26
27% more funds holding
Funds holding: 90 → 114 (+24)
14% more capital invested
Capital invested by funds: $1.41B → $1.6B (+$197M)
0.75% more ownership
Funds ownership: 71.72% → 72.48% (+0.75%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
114
Holders Change
+24
Holders Change %
+26.67%
% of All Funds
2.47%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
31
Increased
37
Reduced
26
Closed
7
Calls
$48K
Puts
$2K
Net Calls
+$46K
Net Calls Change
+$48K
Top Buyers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$16.2M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$12M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$5.3M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$4.55M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.16M |
